Although the small DNA tumor virus SV40 (simian virus 40) fails to replicate in human cells, understanding how SV40 transforms human and murine cells has and continues to provide important insights into cancer initiation and maintenance. The early region of SV40 encodes two oncoproteins: the large T (LT) and small t (ST) antigens. SV40 LT contributes to murine and human cell transformation in part by inactivating the p53 and retinoblastoma protein tumor suppressor proteins. SV40 ST inhibits the activity of the protein phosphatase 2A (PP2A) family of serine-threonine phosphatases, and this interaction is required for SV40-mediated transformation of human cells. PP2A regulates multiple signaling pathways, suggesting many possible targets important for viral replication and cell transformation. Genetic manipulation of particular PP2A subunits has confirmed a role for specific complexes in transformation, and recent work implicates the perturbation of the phosphatidylinositol 3-kinase/Akt pathway and c-Myc stability in transformation by ST and PP2A. Mutations in PP2A subunits occur at low frequency in human tumors, suggesting that alterations of PP2A signaling play a role in both experimentally induced and spontaneously arising cancers. Unraveling the complexity of PP2A signaling will not only provide further insights into cancer development but may identify novel targets with promise for therapeutic manipulation.
Introduction
Transforming viruses such as adenovirus, polyoma virus, simian virus 40 (SV40), and human papilloma virus (HPV) have proven to be valuable tools in the study of tumorigenesis. Each of these viruses encodes genes whose protein products disable key cellular regulatory proteins that permit viral replication. Some of the proteins targeted by these viral proteins play important roles in growth regulation, and in some cells, inactivation of these regulatory proteins by these viral products leads to cell transformation.
For example, the study of viral oncoproteins provided key insights into our understanding the function of the p53 and retinoblastoma protein (pRB) tumor suppressor proteins, whose inactivation relieves important checkpoints on cell growth control and cell cycle progression. p53 and pRB are targeted by E1A and E1B of adenovirus (reviewed in Moran, 1993) , the multifunctional large T (LT) antigen of SV40 (reviewed in Ali and DeCaprio, 2001) , and E6 and E7 of HPV (reviewed in Munger and Howley, 2002) . While inactivation of p53 and pRB is required for the transformation of human cells, expression of the viral oncoproteins that target p53 and pRB alone fails to transform human cells, and adenovirus, polyoma, and SV40 encode additional oncoproteins whose activity is also necessary to achieve transformation. The study of adenovirus E4orf4, polyoma small t (ST) and middle T (MT) antigens, and SV40 ST antigen, all of which contribute to transformation, has directed research to a common cellular target: protein phosphatase 2A (PP2A).
PP2A accounts for a majority of the serine-threonine phosphatase activity in cells and has been implicated in the regulation of many signaling pathways and phenotypes. PP2A holoenzymes exist as heterotrimeric complexes, and the E4orf4, MT, and ST oncoproteins bind to and perturb the enzymatic activity of such complexes. Work with SV40 ST in particular has revealed that inactivation of PP2A complexes plays an important role in the experimental transformation of human cells. In addition, several studies have identified alterations in specific PP2A subunits in human cancers. In this review, we will discuss how the study of SV40 ST and PP2A has elucidated new regulatory mechanisms involved in human cell transformation.
Cell transformation by SV40
SV40 is a DNA tumor virus with a genome of B5 kb and is one of the best-studied members of the polyomavirus family (reviewed in Cole, 1996) . Infection of monkey cells, such as CV-1 green monkey kidney cells, by SV40 leads to replication of the viral genome and production of SV40 viral particles that result in the lysis of the host cell. Cells that support viral replication are said to be permissive hosts for SV40. However, infection of nonpermissive rodent cells induces cell transformation and tumor formation instead of cell lysis because such cells lack factors required to support viral replication. By determining the viral functions necessary to induce transformation in nonpermissive cells, researchers have used SV40 to gain insight into the process of tumorigenesis.
The structure of the SV40 genome is divided into an early region and a late region based on when each region is expressed following SV40 infection (reviewed in Cole, 1996) . The early region encodes the LT and ST antigens, to which animals bearing SV40-induced tumors produce specific antibodies, while the late region encodes the three viral capsid proteins VP1, VP2, and VP3. In nonpermissive cells, only the early region is expressed, and the early region functions are required for cell transformation. The two early region gene products are immunologically related, and peptide mapping showed that the proteins share a common 5 0 -coding region (Prives et al., 1977; Paucha et al., 1978) . Mapping of SV40 deletion mutants demonstrated that LT and ST are encoded by alternative splicing of the early region (Crawford et al., 1978; Sleigh et al., 1978) . The two mRNAs have identical 5 0 and 3 0 sequences, but the ST mRNA contains a unique exon that encodes the ST-specific amino acids along with a stop codon (Berk and Sharp, 1978; Crawford et al., 1978) . Thus, LT and ST share a common amino-terminal domain of 82 amino acids, but possess different carboxy-terminal regions.
The functions of LT are essential to transform nonpermissive cells (reviewed in Ali and DeCaprio, 2001) . LT binds to p53 as well as pRB and the closely related proteins p107 and p130. The carboxy-terminal half of LT binds to p53 through bipartite interactions (Lane and Crawford, 1979; Linzer and Levine, 1979; Schmieg and Simmons, 1988) and results in the stabilization of p53 protein but inhibition of p53 function (Oren et al., 1981; Mietz et al., 1992; Segawa et al., 1993) . Binding to and inhibition of pRB, p107, and p130 is mediated by the LxCxE motif of LT, which is also found in the pRB-binding proteins of adenovirus and HPV (DeCaprio et al., 1988; Dyson et al., 1989; Ewen et al., 1989) . Inactivation of the pRB protein family is enhanced by the LT amino-terminal domain shared with ST, which functions as a J domain (Srinivasan et al., 1997; Stubdal et al., 1997; Zalvide et al., 1998) . Genetic analysis of SV40 demonstrated that LT is required for transformation of rodent cell lines (Brugge and Butel, 1975; Martin and Chou, 1975; Tegtmeyer, 1975) . Mutation of the p53-binding domain, the pRB family-binding domain, or the J domain prevents transformation by LT, indicating that LTmediated inhibition of p53 and the pRB family proteins is required to induce transformation (Zhu et al., 1992) . Additionally, LT binds the transcriptional coactivators p300/CBP and the related p400 along with heat-shock protein 70, and these interactions enhance the transforming ability of LT (reviewed in Ali and DeCaprio, 2001) . Besides transforming functions, LT is also responsible for replication of the viral genome and regulated expression of both the early and late region promoters (reviewed in Fanning and Knippers, 1992) . However, viral replication functions of LT can be genetically separated from the transformation activity of LT, indicating that they are not required for transformation (Gluzman and Ahrens, 1982; Kalderon and Smith, 1984) .
The role of ST in cell transformation
While early studies showed that LT was required for the morphological transformation of rodent cell lines by SV40, further investigation into the role of ST revealed that the full spectrum of transforming phenotypes in many rodent cell lines also required ST activity. Specifically, SV40 deletion mutants that affected the ST-specific exon had normal viability (Shenk et al., 1976; Crawford et al., 1978; Sleigh et al., 1978) , but were deficient in some transformation assays. For example, when transformation was measured by the dense focus assay or anchorage-independent growth, SV40 ST deletion mutants failed to transform Rat-1, REF, and NIH 3T3 cells (Sleigh et al., 1978; Fluck and Benjamin, 1979) . However, when assays such as colony formation following low plating density were used, no differences were observed in the ability of these same SV40 mutants to transform cells as compared to wild-type viruses (Shenk et al., 1976; Sleigh et al., 1978) . These early experiments revealed that ST activity was necessary to elicit some of the phenotypes of transformation and suggested that ST might have a specific role in the transformation process that was not provided by LT activity.
The requirement of both LT and ST for robust transformation has been confirmed in a variety of rat, mouse, and hamster cell lines (Rubin et al., 1982; Chang et al., 1984) , and point mutations within the ST-specific coding region were shown to block transformation similarly to ST deletion mutants . In general, while expression of LT and ST from independent retroviral expression vectors has yielded the same results as seen with engineered SV40 viruses (Chang et al., 1984) , retroviral expression has also provided insights into the dynamics of LT and ST function. In NIH 3T3 cells, expression of LT from a retrovirus led to anchorage-independent growth in the absence of ST, contrary to earlier studies Jat et al., 1986) . These results were reconciled by the observation that, in the murine A31 cell line, the level of LT expression was inversely correlated with the requirement for ST in transformation (Bikel et al., 1987) . ST was only necessary for efficient transformation when LT was expressed from an SV40 virus at relatively low levels, while LT expression from a retrovirus lead to significantly higher levels of LT and no requirement for ST.
These data suggest that the increased expression of LT was sufficient to overcome the usual requirement for ST (Bikel et al., 1987) . This work also supports the view that in rodent systems, the primary transforming function of ST is to drive cell proliferation, which can be accomplished by high levels of LT. Consistent with this hypothesis, activated Ras can also transform murine cells in the context of LT expression (Michalovitz et al., 1987; Hirakawa and Ruley, 1988) . Furthermore, transgenic mice expressing LT from an MMTV retroviral vector develop lymphomas, which are derived from already rapidly dividing cells, while tumor formation from the normally slowly dividing epithelial cells of the lung and kidney occurs with the additional expression of ST (Choi et al., 1988) . Taken together, these studies demonstrate that for rodent cells, ST functions are not required but enhance transformation induced by limited LT.
The SV40 early region oncoproteins also contribute to the transformation of human cells. In contrast to rodent cells, human cells are more resistant to transformation (Sager et al., 1983; Chang et al., 1985) . While expression of LT in human cells is sufficient to bypass cellular senescence, immortalization requires the additional expression of the human telomerase catalytic subunit (hTERT) (reviewed in Lustig, 1999) . Furthermore, human cells expressing LT remain morphologically normal, but expression of both SV40 oncoproteins induces morphological changes reminiscent of cell lines derived from tumors (Sager et al., 1983; Chang et al., 1985; de Ronde et al., 1989) . Some human cells expressing LT and ST are also able to grow in an anchorage-independent manner in short-term assays (Chang et al., 1985; Yu et al., 2001) , but not all cell types are capable of such growth (Sager et al., 1983; Rangarajan et al., 2004) . However, to generate fully transformed human cells capable of tumor formation in nude mice, the expression of hTERT and an oncogenic allele of Ras is necessary in addition to LT and ST (Yu et al., 2001; Hahn et al., 2002; Rangarajan et al., 2004) . As transformation in the context of LT, hTERT, and oncogenic Ras expression is fully dependent upon the additional expression of ST (Yu et al., 2001; Hahn et al., 2002) , this model provides an experimental system for the study of ST in human cell transformation.
Examination of ST mutants has provided important clues to the functions of ST during cell transformation. Mutations in ST that prevent the interaction with and inhibition of PP2A demonstrate that this interaction is required for ST-mediated transformation (Hahn et al., 2002) . In a PP2A-independent manner, ST also transactivates the cyclin A promoter (Porras et al., 1996) and possesses chaperone activity from its J domain (Srinivasan et al., 1997) . While such functions may contribute to ST-mediated transformation, they are not required since a mutant of ST that contains only the PP2A-inactivation domain (amino acids 88-174) retains the ability to induce transformation (Hahn et al., 2002) . These observations suggest that the primary transforming activity of ST is to disrupt PP2A complexes, which in turn perturbs PP2A activity, thereby altering the phosphorylation status of many signaling molecules.
The ST-PP2A connection
The best-studied function of SV40 ST is its ability to interact with PP2A. The interaction between ST and two cellular proteins, later identified as the PP2A A and C subunits (Pallas et al., 1990; Walter et al., 1990) , was initially determined in immunoprecipitation experiments in SV40-infected monkey cells (Yang et al., 1979; Rundell et al., 1981) . An antisera that detected LT and ST co-immunoprecipitated the two proteins, which specifically interacted with ST since they were not coimmunoprecipitated from cells infected with ST deletion mutants of SV40 (Yang et al., 1979; Rundell et al., 1981) . Two-dimensional gel electrophoresis revealed that the same proteins also associated with the ST and MT antigens of the polyoma virus (Pallas et al., 1988; Walter et al., 1988) . Unlike p53, which is stabilized by its interaction with SV40 LT (Oren et al., 1981) , the proteins that interact with ST are present at equivalent levels before and after SV40 infection, indicating that ST does not affect their stability (Rundell, 1982) .
In vitro experiments with purified proteins demonstrated that ST interacts directly with the PP2A A subunit and is associated with the C subunit only through the A subunit (Yang et al., 1991; Ruediger et al., 1992) . Studies using PP2A A subunit deletion mutants demonstrated that the C subunit binds to the carboxy-terminus of the A subunit, while ST binds to the amino-terminus (Ruediger et al., 1992) . The binding site for the PP2A B subunits also maps to the aminoterminus and overlaps with the ST binding site, suggesting that ST competes with the B subunits for binding to the A subunit (Ruediger et al., 1994) . The ability of ST to displace multiple B subunits from the A subunit has been confirmed in vivo (Sontag et al., 1993; Chen et al., 2004) .
Studies of PP2A phosphatase activity demonstrated that ST alters the in vitro activity of the AC complex. In general, ST inhibits PP2A activity toward multiple substrates, including SV40 LT and p53, although for one substrate tested, histone H1, the presence of ST increased phosphatase activity (Scheidtmann et al., 1991; Yang et al., 1991) . By using ST mutants that are unable to inhibit in vitro PP2A activity, multiple groups explored the relationship between the structure and function of ST. Mutations in the unique carboxyterminal region of ST, specifically point mutation of residues Cys-97, Pro-101, and Cys-103, as well as deletion of residues 110-119, block ST association with the A subunit (Mungre et al., 1994; Mateer et al., 1998) , and thus prevent inhibition of catalytic activity. In vivo, ST expression stimulates growth factor signaling pathways, such as the MAP kinase and stress-activated protein kinase pathways, and mutants of ST that are unable to bind to the A subunit fail to stimulate these pathways (Sontag et al., 1993; Watanabe et al., 1996) . This work extends the observations made in in vitro activity assays and indicates that ST stimulation of growth-promoting pathways is due to inhibition of PP2A. When combined with earlier experiments demonstrating a role for the ST carboxy-terminal region in transformation by SV40 , these observations indicate that ST inhibition of PP2A contributes to transformation. In a direct test of this hypothesis, ST mutants deficient for PP2A binding failed to transform human cells, defining a role for PP2A activity in transformation (Hahn et al., 2002) .
In contrast to the carboxy-terminus of ST, the aminoterminus is not required for interaction of ST with the A subunit of PP2A (Sontag et al., 1993; Mungre et al., 1994) . This region of ST, which is shared with LT, may contribute to high-affinity binding since its deletion resulted in ST having a lower affinity for the A subunit (Mateer et al., 1998) . However, deletion of the ST amino-terminus does not have any effect on the ability of ST to inhibit PP2A activity (Mateer et al., 1998) . Furthermore, unlike deletion of the PP2A-interaction domain, amino-terminal deletion mutants of ST induce human cell transformation (Hahn et al., 2002) .
Biochemistry and cellular functions of PP2A
PP2A was initially characterized as one of four abundant phosphoserine and phosphothreonine protein phosphatase activities in cellular extracts. The in vivo activity is provided by a large family of related complexes that exist as either heterodimers or heterotrimers (reviewed in Cohen, 1989; Mumby and Walter, 1993) . The heterodimer consists of one catalytic C subunit, known as PP2A C or PPP2C, and one regulatory A subunit, also called PR65 or PPP2R1, while the heterotrimer possesses an additional regulatory B subunit (Figure 1) . A second heterodimer complex is formed by the C subunit interacting with Tap42/a4 in place of the A subunit, and this complex appears to be involved in the regulation of the mTOR pathway (Di Como and Arndt, 1996; Murata et al., 1997; Nanahoshi et al., 1998) as well as apoptosis (Kong et al., 2004) . PP2A subunits are evolutionarily conserved (Orgad et al., 1990; Sneddon et al., 1990; Mayer-Jaekel et al., 1992) , although the number and diversity of PP2A B subunits is considerably increased in mammals. In mammals, two genes encode different isoforms of the PP2A A and C subunits. The two isoforms of the C subunit, referred to as Ca and Cb, are 97% identical at the protein level, with only eight amino-acid differences that are clustered in the amino-terminus (da Cruz e Silva and Cohen, 1987; Stone et al., 1987; Arino et al., 1988) . Despite this high degree of identity, some evidence suggests that the two isoforms have nonredundant functions (Gotz et al., 1998 (Gotz et al., , 2000 . The free C subunit can be purified in vitro from the AC dimer and possesses phosphatase activity that is regulated by the binding of the A subunit (Usui et al., 1988) . However, the C subunit is not observed as a free subunit in cells.
The two PP2A A subunit isoforms, Aa and Ab, are 87% identical, with the Aa isoform being approximately 10-fold more abundant than the Ab isoform (Hemmings et al., 1990; Zhou et al., 2003) . The crystal structure of the free A subunit confirmed earlier models for the A subunit as a rod-shaped molecule consisting of 15 nonidentical HEAT repeats (Ruediger et al., 1994; Groves et al., 1999) . Each HEAT repeat, named for its presence in huntingtin, elongation factor 3, A subunit of PP2A, and TOR, is involved in protein-protein interactions and contains two packed amphipathic alpha helixes connected by a short loop (Ruediger et al., 1994; Andrade and Bork, 1995) . The HEAT repeats mediate binding of the A subunit to the other subunits in PP2A complexes (Ruediger et al., 1992 (Ruediger et al., , 1994 . The aminoterminal repeats 1-10 are responsible for binding a B subunit, while the carboxy-terminal HEAT repeats 11-15 bind to the C subunit. Compared to the Aa isoform, the Ab isoform demonstrates significantly lower affinity for the B and C subunits . While the A subunit serves primarily a structural role, point mutations in the A subunits can disrupt the binding of specific B subunits, suggesting that the A Figure 1 PP2A holoenzyme composition. The PP2A A subunit (PR65 or PPP2R1) exists in mammals as Aa and Ab isoforms. Both isoforms consist of 15 HEAT repeats (indicated as numbered sections of PP2A A) that mediate binding of the regulatory B and catalytic C subunits. The C subunit (PP2A C or PPP2C) binds to HEAT repeats 11-15 and also exists as two isoforms, Ca and Cb. Four families of cellular B subunits have been identified to date, and a single B subunit binds to HEAT repeats 1-10 to complete the complex. The B family (also the B55, PR55, or PPP2R2 family) subunits are encoded by four genes (indicated in the figure in parentheses), while five genes encode subunits of the B 0 family (also the B56, PR61, or PPP2R5 family). The B 00 family (also the PR72 or PPP2R3 family) consists of four isoforms encoded by three genes. Two calmodulin-binding proteins comprise the B 000 family. In addition, SV40 ST interacts with the B subunit-binding region of the PP2A A subunit, resulting in the displacement of the B subunits from the PP2A complex subunits may regulate the composition of cellular PP2A complexes (Ruediger et al., 2001a, b) .
PP2A complexes exist in vivo predominantly as heterotrimers, with a B subunit bound to the AC core dimer (Silverstein et al., 2002) (Figure 1) . Crosslinking experiments have demonstrated that in addition to direct binding of the B and C subunits to the A subunit, there are interactions between the B and C subunits when bound to A (Kamibayashi et al., 1992) . Moreover, mutation of the highly conserved carboxy-terminal nine residues of the C subunit reduces or abolishes B subunit binding, indicating a role for the C subunit in recruitment of the B subunit (Ogris et al., 1997) .
Four unrelated families of B subunits have been identified to date, and several different nomenclature systems are present in the literature. The B family, also referred to as B55, PR55, or PPP2R2, consists of a, b, g, and d isoforms (Mayer et al., 1991; Zolnierowicz et al., 1994; Strack et al., 1999) . The B 0 family, known as well as B56, PR61, or PPP2R5, contains a, b, g, d, and e isoforms (McCright and Virshup, 1995; Csortos et al., 1996; Tehrani et al., 1996) . Within both of these families, some isoforms exist as multiple variants encoded by alternative splicing. The B 00 family, also named PR72 or PPP2R3, is comprised of the PR48/ PR70, PR59, PR72, and PR130 isoforms, the last two of which are alternatively spliced from a single gene (Hendrix et al., 1993; Voorhoeve et al., 1999; Yan et al., 2000; Stevens et al., 2003) . Recently, a fourth family, called B 000 , was identified and consists of the calmodulin-binding proteins PR93/SG2NA and PR110/ Striatin (Moreno et al., 2000) . Including alternative transcripts, there are over 20 known B subunits. These B subunits function to regulate the activity and substrate specificity of PP2A complexes (Mumby et al., 1987; Usui et al., 1988; Kamibayashi et al., 1994; Mayer-Jaekel et al., 1994) . Furthermore, the B subunits determine the subcellular localization of the complexes (Sontag et al., 1995; Tehrani et al., 1996) , and some isoforms show tissue-and developmental stage-specific expression patterns (McCright and Virshup, 1995; Csortos et al., 1996; Martens et al., 2004) .
The diversity of PP2A B subunits, as well as A and C subunits, allows for the formation of many distinct complexes with PP2A activity. Studies in model systems have revealed the breadth of cellular functions regulated by PP2A complexes and also demonstrated that the subunit composition defines specific functions for different complexes (Ferrigno et al., 1993; Zhao et al., 1997; Gotz et al., 2000; Silverstein et al., 2002) . In all organisms examined, PP2A catalytic activity is necessary for cell survival (Sneddon et al., 1990; Gotz et al., 1998; Silverstein et al., 2002; Strack et al., 2004) . In Drosophila, loss of all PP2A complexes or specific loss of complexes containing B56 subunits leads to apoptosis (Silverstein et al., 2002) , while in rat PC6-3 cells, suppression of Aa subunit expression induced both apoptotic and nonapoptotic cell death (Strack et al., 2004) . In addition to apoptosis and cell survival, PP2A complexes are involved in cell cycle regulation (Healy et al., 1991; Ferrigno et al., 1993 ; and reviewed in Zolnierowicz, 2000) , cell adhesion (Gotz et al., 2000; Suzuki et al., 2005) , the DNA damage response (Goodarzi et al., 2004) , and embryonic development (Gotz et al., 1998 (Gotz et al., , 2000 .
A major function of PP2A activity, especially as it relates to cell transformation, is to regulate cell signaling cascades by opposing the activity of signaling kinases (reviewed in Millward et al., 1999) . PP2A complexes have been implicated in the regulation of the MAPK, Wnt, phosphatidylinositol 3-kinase (PI3K), NF-kB, PKC, and Ca 2 þ -calmodulin-dependent signaling pathways as well as downstream targets of these and other pathways. For most pathways, the specific constituents of the regulatory PP2A complexes have not yet been determined. PP2A dephosphorylates multiple components of these signaling pathways in vitro, and increasing in vivo evidence supports the physiological relevance of many of these interactions.
PP2A and human cell transformation
Initial evidence of a role for PP2A in cell transformation and tumorigenesis came from work with the sponge toxin okadaic acid (OA). Studies showed that OA was both a selective inhibitor of PP2A and a potent tumor promoter in mice, although at high concentrations, OA also inhibits PP1 activity (Bialojan and Takai, 1988; Suganuma et al., 1988) . Nevertheless, these observations suggested that inhibition of PP2A contributes to tumor promotion.
The involvement of PP2A in transformation was further supported by the determination that ST binds to the A and C subunits of PP2A. As discussed above, ST served as a valuable tool for studying PP2A function as it relates to transformation, since inhibition of PP2A complexes by ST is required for transformation in an ST-dependent system (Hahn et al., 2002) . In this model, specific suppression of the PP2A B56g subunit was able to replace ST and induce anchorage-independent growth and tumor formation . Moreover, overexpression of PP2A B56g, also referred to as B 0 a, reversed ST-induced transformation. In contrast, suppression of the PP2A B55a subunit was unable to transform cells, and B55a overexpression did not inhibit transformation by ST. These findings suggest that PP2A complexes containing the B56g subunit are specifically involved in transformation in this system .
As PP2A complexes regulate a variety of signaling pathways and cell processes, the mechanism by which PP2A dysfunction induces transformation remains elusive. Furthermore, the diversity of PP2A functions suggests that inactivation of PP2A complexes may alter multiple pathways simultaneously, each of which may contribute independently to cell transformation. Transcriptional analysis of human cells transformed by ST expression or by PP2A B56g suppression revealed that transcription factors FOXD1 and HOXB3, cell adhe-sion molecules, and antiapoptotic targets of NF-kB may be involved in PP2A-mediated transformation (Moreno et al., 2004) . Consistent with a possible effect on cell adhesion, the core PP2A AC dimer forms complexes with Rac, b1-integrin, and IQGAP1, and plays a role in the recruitment of IQGAP1 to that complex (Suzuki et al., 2005) . Furthermore, the finding of NF-kB targets correlates with the ability of PP2A activity to inactivate the IkB kinase, a positive regulator of NF-kB signaling (DiDonato et al., 1997) , and underscores the growing evidence for the control of apoptosis by PP2A complexes. In experiments with the Bcl-2 family of apoptotic regulatory proteins, PP2A dephosphorylated and altered the activity of the proapoptotic BAD and antiapoptotic Bcl-2 proteins (Chiang et al., 2003; Simizu et al., 2004) . However, these data suggest both pro-and antiapoptotic effects for PP2A complexes, and the role of specific complexes remains unclear.
Moreover, a number of known oncogenes and tumor suppressors have been implicated as possible targets of PP2A dysregulation. In regulation of the Wnt pathway, PP2A complexes containing B56 subunits bind to both APC and Axin within the b-catenin regulatory complex, and PP2A activity affects Wnt signaling upstream and downstream of b-catenin (Hsu et al., 1999; Seeling et al., 1999; Yamamoto et al., 2001 ). In addition, PP2A complexes containing the PR72 subunit negatively regulate Wnt signaling through interaction with another negative regulator, Naked cuticle (Creyghton et al., 2005) . Thus, PP2A complexes modulate Wnt signaling through a variety of mechanisms, although those involving B56 subunits may be of more relevance to transformation given the phenotype of cells lacking PP2A B56g .
Apart from the Wnt pathway, PP2A complexes and b-catenin have additional interactions, and the PP2A Ca subunit is required for proper localization of E-cadherin and b-catenin to the plasma membrane (Gotz et al., 2000) . This observation suggests a possible role for PP2A activity in the epithelial-mesenchymal transition and invasiveness. As with the Wnt pathway, the MAP kinase cascade is regulated at multiple steps by PP2A complexes. Studies have demonstrated direct regulation of Raf, MEK, ERK, and KSR (Sontag et al., 1993; Ory et al., 2003; Dougherty et al., 2005) , with the B55 subunit specifically mediating inhibition of ERK in Drosophila (Silverstein et al., 2002) .
In addition, recent studies have linked PP2A complexes to the regulation of two transcription factors involved in cancer development: p53 and c-Myc. Through interaction with cyclin G, PP2A complexes containing B56 subunits were implicated in the inhibition of MDM2 and the stabilization of p53 (Okamoto et al., 2002) . Meanwhile, polyoma ST, which functions similarly to SV40 ST, inhibits ARF-mediated activation of p53 in a PP2A-dependent manner (Moule et al., 2004) . However, while these findings imply that inhibition of PP2A complexes perturbs p53 activation, such an effect is not sufficient to transform human cells in the absence of direct inhibition of p53 by LT or other means (Voorhoeve and Agami, 2003; Wei et al., 2003; Rangarajan et al., 2004) . c-Myc, on the other hand, is directly dephosphorylated by PP2A, and inhibition of PP2A activity by ST stabilizes c-Myc (Yeh et al., 2004) . Furthermore, in ST-dependent transformation assays, a stabilized c-Myc mutant can substitute for ST expression (Yeh et al., 2004) . Taken together, these data suggest that stabilization of c-Myc following disruption of PP2A complexes contributes to transformation.
Several lines of evidence also implicate a strong connection between PP2A and the PI3K/Akt pathway. As with c-Myc, genetic substitution experiments demonstrate that either activated PI3K or a combination of the activated PI3K effectors Akt and Rac1 induce human cell transformation in place of ST expression (Zhao et al., 2003) . Conversely, blocking PI3K function inhibited ST-mediated transformation. Consistent with these results, both the treatment of cells with the PP2A inhibitor OA (Andjelkovic et al., 1996) and expression ST inhibits all PP2A complexes, including the specific complexes containing the B55a (Ba) or B56g (B 0 a) subunits, while gene suppression using short-hairpin RNAs (shRNAs) can be used to target directly complexes containing B55a (not indicated) or B56g. Of possible relevance to cell transformation, PP2A complexes regulate the Wnt/b-catenin signaling pathway and the Bcl-2 family of apoptosis regulators as well as activating p53 and inhibiting p70 S6K and c-Myc. However, it is unclear which specific PP2A complexes are responsible for these activities. Although PP2A B55a-containing complexes have not yet been directly linked to cell transformation, PP2A B56g-containing complexes are implicated in the inhibition of Akt activity and the expression of antiapoptotic NF-kB targets. Studies to date suggest that of the PP2A targets shown, stabilization of c-Myc and activation of Akt contribute to cell transformation mediated by ST expression or PP2A B56g suppression of ST activates Akt (Yuan et al., 2002; Zhao et al., 2003) . When PP2A complexes are directly disrupted by suppression of the PP2A B56g, Aa, or Ab subunits, we observe the same activation of Akt (W Chen, J Arroyo, WC Hahn, unpublished observations). These studies strongly implicate activation of the Akt pathway in human cell transformation induced by PP2A dysfunction. While Akt is one target of PP2A, PP2A complexes may also act downstream of Akt in the mTOR pathway. PP2A complexes bind to the mTOR substrate p70 S6K in vivo and inhibit its activity in vitro (Ballou et al., 1988; Westphal et al., 1999) . The interaction with p70 S6K suggests that PP2A activity is involved in nutrient signaling, which is consistent with the observation that ST expression or suppression of PP2A B56g enhances the ability of cells to proliferate in low-nutrient conditions (Hahn et al., 2002; Chen et al., 2004) . One potential model of the interactions of ST and PP2A in human cell transformation is depicted in Figure 2 . However, despite these findings, additional work is necessary to determine which of the many pathways discussed above are directly involved in PP2A-mediated transformation.
Disruption of PP2A in cancer
While the evidence exists implicating PP2A complexes, especially those containing B56g or other B56 subunits, in human cell transformation, demonstration of a direct relevance to spontaneously arising human cancer has been more limited. The majority of the work has involved screening tumor samples and cell lines for mutations in PP2A subunit genes. The most frequent alterations have been identified in the gene encoding the Ab subunit, primarily in human lung and colorectal cancers, and also in breast cancers (Wang et al., 1998; Calin et al., 2000; Takagi et al., 2000; Tamaki et al., 2004) . These investigators found point mutations, deletions, and loss of heterozygosity at the Ab locus, PPP2R1B, which resulted in disruption of both alleles in most cases, suggesting that PP2A Ab may function as a tumor suppressor gene. For all but one of the Ab mutants examined, the mutation generated a loss-offunction allele that can neither bind to B and/or C subunits nor support phosphatase activity (Ruediger et al., 2001a; W Chen, J Arroyo, WC Hahn, unpublished observations) . The only exception is the G90D mutation, which is observed in tumors and normal tissues along with a wild-type allele, shows normal functions in vitro, and is thus likely a polymorphism (Wang et al., 1998; Campbell and Manolitsas, 1999; Ruediger et al., 2001a) .
Mutations of the more abundant PP2A Aa subunit, PPP2R1A, have also been observed, although at a low frequency (Calin et al., 2000) . As with the Ab mutations, the reported mutations in the PP2A Aa subunit are loss-of-function and lead to deficiencies in binding the B and/or C subunits and in phosphatase activity (Ruediger et al., 2001b) . While mutations of PP2A Aa are rare, decreased expression of the Aa subunit has been observed in brain tumors at high frequency (Colella et al., 2001) and in the MCF-7 breast cancer cell line (Suzuki and Takahashi, 2003) . In contrast to mutation or decreased expression, complete suppression of PP2A Aa expression is lethal in rat PC6-3 cells (Strack et al., 2004) . Thus, a minimum of PP2A Aa function is likely required to maintain cell viability.
Whether other PP2A subunits are mutated in human cancers remains unclear. In the case of the PP2A B56g subunit, there are conflicting studies on how expression of this subunit is altered in melanomas. While one group reported higher expression levels of the PP2A B56g mRNA in human melanoma cell lines compared to normal melanocytes (Francia et al., 1999) , a second group observed decreased expression in primary human melanoma samples compared to melanocytic naevi (Deichmann et al., 2001) . However, analysis of a sample of 10 lung cancer cell lines failed to detect PP2A B56g at the protein level . In addition, a truncated B56g1 isoform is expressed in a metastatic clone, BL6, of mouse B16 melanoma cells (Ito et al., 2000) . This truncated B56g1 isoform disrupts in vitro PP2A phosphatase activity compared to wild-type B56g1 and is sufficient to enhance the metastasis of another clone, F10. Taken together, the identification and analysis of human cancer-associated mutations in PP2A subunits support the involvement of PP2A complexes in tumorigenesis. However, further studies are needed in this area to explore the connection between PP2A dysfunction and human cancer development.
Concluding remarks
Studies of the SV40 ST oncoprotein have provided valuable insight into the mechanisms involved in human cell transformation. While ST has a number of functions, its ability to perturb PP2A activity has emerged as the most relevant to cell transformation. Given the numerous pathways regulated by PP2A complexes, disruption of these complexes is an efficient mechanism for a virus to alter many cellular processes simultaneously. Similarly, dysfunction of PP2A complexes may contribute to cell transformation through effects on several signaling pathways. In model systems, different PP2A subunits demonstrate specific functions, and the emerging view suggests that particular complexes will be primarily responsible for the changes that lead to transformation. Future work will continue to dissect the mechanisms by which disruption of PP2A complexes contributes to cell transformation. Furthermore, we expect that increasing evidence from tumor samples will elucidate a clear role for PP2A dysfunction in the progression of a variety of human cancers.
